The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model
暂无分享,去创建一个
T. Beißbarth | S. Koenig | P. Krause | A. Bleckmann | C. Hackl | G. Salinas | Alexander Wolff | D. Bocuk | T. Beissbarth
[1] M. Ando,et al. Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G). , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Etienne Becht,et al. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.
[3] L. Naldini,et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment , 2016, EMBO molecular medicine.
[4] B. Melichar,et al. Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry. , 2015, Anticancer research.
[5] Jeong-Hwan Kim,et al. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels , 2015, Oncotarget.
[6] A. Khorana,et al. Integrating systemic and surgical approaches to treating metastatic colorectal cancer. , 2015, Surgical oncology clinics of North America.
[7] Richard R. Smith,et al. Liver-directed therapies in metastatic colorectal cancer. , 2014, Journal of gastrointestinal oncology.
[8] T. Hielscher,et al. Metastasis-Related Processes Show Various Degrees of Activation in Different Stages of Pancreatic Cancer Rat Liver Metastasis , 2014, Oncology Research and Treatment.
[9] Jie Cao,et al. Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression , 2014, OncoTargets and therapy.
[10] R. Machii,et al. Five-year relative survival rate of colon cancer in the USA, Europe and Japan. , 2014, Japanese journal of clinical oncology.
[11] O. Bathe,et al. Identification of prognostic inflammatory factors in colorectal liver metastases , 2014, BMC Cancer.
[12] E. Ager,et al. Bimodal role of Kupffer cells during colorectal cancer liver metastasis , 2013, Cancer biology & therapy.
[13] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[14] Su-Hyung Hong,et al. Phosphatase of regenerating liver‐3 promotes migration and invasion by upregulating matrix metalloproteinases‐7 in human colorectal cancer cells , 2012, International journal of cancer.
[15] J. Kamps,et al. Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases: The Liver as a Permissive Soil , 2012, Annals of surgery.
[16] Robert A. Weinberg,et al. Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.
[17] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[18] William C Hines,et al. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression , 2011, Nature Medicine.
[19] I. Fidler,et al. AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.
[20] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[21] J. Yun,et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer , 2009, International Journal of Colorectal Disease.
[22] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[23] 落合 大樹. A new formula for predicting liver metastasis in patients with colorectal cancer : immunohistochemical analysis of a large series of 439 surgically resected cases , 2009 .
[24] Alexander D. Diehl,et al. Access to immunology through the Gene Ontology , 2008, Immunology.
[25] S. Hirohashi,et al. A New Formula for Predicting Liver Metastasis in Patients with Colorectal Cancer: Immunohistochemical Analysis of a Large Series of 439 Surgically Resected Cases , 2008, Oncology.
[26] C. Nadal,et al. Is there a genetic signature for liver metastasis in colorectal cancer? , 2007, World journal of gastroenterology.
[27] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[28] G. Launoy,et al. A population‐based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer , 2006, The British journal of surgery.
[29] K. Hayashi,et al. Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer , 2006, Clinical Cancer Research.
[30] L. Matrisian,et al. Matrix metalloproteinases in colorectal cancer: Is it worth talking about? , 2004, Cancer and Metastasis Reviews.
[31] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[32] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[33] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[34] René Bernards,et al. A progression puzzle. , 2002, Nature.
[35] J. Guillem,et al. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] R Kath,et al. Tumor progression and metastasis , 1990, Zentralblatt fur Chirurgie.
[37] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .